BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
University of Edinburgh divulges new 11-beta-HSD1 inhibitors
Jan. 17, 2011
Lupin divulges new dipeptidyl peptidase 4 inhibitors
Jan. 17, 2011
FDA accepts NDA for extended-release Janumet for review
Jan. 14, 2011
Omthera reports bioavailability data from ECLIPSE trial of Epanova
Jan. 13, 2011
Dara BioSciences presents additional data from phase I DB-959 trial
Jan. 12, 2011
EffRx Pharma submits NDA to FDA for EX-101
Jan. 12, 2011
Esperion begins phase II trial of ETC-1002 in lipid regulation
Jan. 12, 2011
Zydus-Cadila discloses new GPR119 receptor agonists
Jan. 12, 2011
New melanin-concentrating hormone MCH1 receptor antagonists disclosed
Jan. 12, 2011
AstraZeneca patents new diacylglycerol O-acyltransferase 1 inhibitors
Jan. 12, 2011
Previous
1
2
…
642
643
644
645
646
647
648
649
650
…
1792
1793
Next
RSS